2751. Cefiderocol Use in Treating Patients with Confirmed Stenotrophomonas maltophilia Infections in US Hospitals During January 2020 - June 2022

BACKGROUND: Stenotrophomonas maltophilia (SM) infections have been associated with high mortality rates (21% to 69%), particularly in critically ill patients because of SM inherent resistance to many antibiotics, including carbapenems. This study describes cefiderocol (CFDC) treating hospitalized pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Bin, Nguyen, Sean T, Copeland, Jennifer D, Song, Hyun Jin, Slover, Christine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679100/
http://dx.doi.org/10.1093/ofid/ofad500.2362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679100/
http://dx.doi.org/10.1093/ofid/ofad500.2362

Ejemplares similares